A clinical study, the Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS), demonstrated that treatment with perindopril, a centrally active ACE inhibitor, reduces the risk of severe cognitive decline and stroke-related dementia [27,28]. The gene discussed is ACE; the disease is Stroke.